UAB 1815: Phase 2 Trial of Intensive Chemo-immu,otherapy with Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Relapsed.Refractory Myeloma In the context of Salvage Autologous Hematopoietic Cell Transplantation

Grant

Awarded By

Total Award Amount

  • 132000.00

    • Direct Costs

  • 101538.00

    • Sponsor Award Id

    • Contributor

  • Kelly Godby M.D.   Investigator  
  • Lorena De Idiaquez Bakula   Investigator  
  • Luciano Costa M.D., Ph.D.   Principal Investigator  
  • Racquel Innis-Shelton M.D.   Investigator  
  • Smith Giri   Investigator  
  • Susan Bal   Investigator